Menu
Currency
GWAS Study

Genome-wide analysis yields new loci associating with aortic valve stenosis.

Helgadottir A, Thorleifsson G, Gretarsdottir S et al.

29511194 PubMed ID
GWAS Study Type
808380 Participants
131 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HA
Helgadottir A
TG
Thorleifsson G
GS
Gretarsdottir S
SO
Stefansson OA
TV
Tragante V
TR
Thorolfsdottir RB
JI
Jonsdottir I
BT
Bjornsson T
SV
Steinthorsdottir V
VN
Verweij N
NJ
Nielsen JB
ZW
Zhou W
FL
Folkersen L
MA
Martinsson A
HM
Heydarpour M
PS
Prakash S
OG
Oskarsson G
GT
Gudbjartsson T
GA
Geirsson A
OI
Olafsson I
SE
Sigurdsson EL
AP
Almgren P
MO
Melander O
FA
Franco-Cereceda A
HA
Hamsten A
FL
Fritsche L
LM
Lin M
YB
Yang B
HW
Hornsby W
GD
Guo D
BC
Brummett CM
AG
Abecasis G
MM
Mathis M
MD
Milewicz D
BS
Body SC
EP
Eriksson P
WC
Willer CJ
HK
Hveem K
NC
Newton-Cheh C
SJ
Smith JG
DR
Danielsen R
TG
Thorgeirsson G
TU
Thorsteinsdottir U
GD
Gudbjartsson DF
HH
Holm H
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Aortic valve stenosis (AS) is the most common valvular heart disease, and valve replacement is the only definitive treatment. Here we report a large genome-wide association (GWA) study of 2,457 Icelandic AS cases and 349,342 controls with a follow-up in up to 4,850 cases and 451,731 controls of European ancestry. We identify two new AS loci, on chromosome 1p21 near PALMD (rs7543130; odds ratio (OR) = 1.20, P = 1.2 × 10-22) and on chromosome 2q22 in TEX41 (rs1830321; OR = 1.15, P = 1.8 × 10-13). Rs7543130 also associates with bicuspid aortic valve (BAV) (OR = 1.28, P = 6.6 × 10-10) and aortic root diameter (P = 1.30 × 10-8), and rs1830321 associates with BAV (OR = 1.12, P = 5.3 × 10-3) and coronary artery disease (OR = 1.05, P = 9.3 × 10-5). The results implicate both cardiac developmental abnormalities and atherosclerosis-like processes in the pathogenesis of AS. We show that several pathways are shared by CAD and AS. Causal analysis suggests that the shared risk factors of Lp(a) and non-high-density lipoprotein cholesterol contribute substantially to the frequent co-occurence of these diseases.

2,457 Icelandic ancestry cases, 349,342 Icelandic ancestry controls (including non-array genotyped, whole genome imputed individuals)

Chapter III

Study Statistics

Key metrics and study information

808380
Total Participants
GWAS
Study Type
Yes
Replicated
4,850 European ancestry cases, 451,731 European ancestry controls
Replication Participants
European
Ancestry
Iceland, U.S., Norway, Sweden, U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.